Neion Bio is a private biomanufacturing platform company using transgenic chicken eggs to produce recombinant proteins at scale. The company's ovum-based expression system promises faster, cheaper production of complex biologics compared to traditional mammalian cell culture.
Company Info
Funding & Investor Relations
None publicly disclosed; pre-commercial biomanufacturing platform company.
Upcoming Milestones & Key Dates
GMP-scale pilot launch for NB-001 enzyme product
First commercial partnerships for egg-based biologics platform
Clinical Development Pipeline
Recent News
Neion Bio raised a $23M Series A to scale its chicken-egg-based recombinant protein production platform, pitching the approach as a low-cost, scalable alternative to CHO-cell bioreactors for certain biologics.
Neion Bio has raised a $23M Series A to develop its platform for producing recombinant proteins in chicken eggs, an alternative to traditional mammalian cell culture manufacturing that promises faster, cheaper biologics production.
Leadership Team
Careers & Job Openings